![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2021
Frontzek, Fabian; Ziepert, Marita; Nickelsen, Maike; Altmann, Bettina; Glass, Bertram; Haenel, Mathias; Truemper, Lorenz; Held, Gerhard; Bentz, Martin; Borchmann, Peter; Dreyling, Martin; Viardot, Andreas; Kroschinsky, Frank P.; Metzner, Bernd; Staiger, Annette M.; Horn, Heike; Ott, German; Rosenwald, Andreas; Loeffler, Markus; Lenz, Georg und Schmitz, Norbert
(2021):
Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial.
In: Lancet Haematology, Bd. 8, Nr. 4, E267-E277
Schmitz, Norbert; Truemper, Lorenz; Bouabdallah, Krimo; Ziepert, Marita; Leclerc, Mathieu; Cartron, Guillaume; Jaccard, Arnaud; Reimer, Peter; Wagner, Eva; Wilhelm, Martin; Sanhes, Laurence; Lamy, Thierry; de Leval, Laurence; Rosenwald, Andreas; Roussel, Muriel; Kroschinsky, Frank; Lindemann, Walter; Dreger, Peter; Viardot, Andreas; Milpied, Noeel; Gisselbrecht, Christian; Wulf, Gerald; Gyan, Emmanuel; Gaulard, Philippe; Bay, Jacques Olivier; Glass, Bertram; Poeschel, Viola; Damaj, Gandhi; Sibon, David; Delmer, Alain; Bilger, Karin; Banos, Anne; Haenel, Mathias; Dreyling, Martin; Metzner, Bernd; Keller, Ulrich; Braulke, Friederike; Friedrichs, Birte; Nickelsen, Maike; Altmann, Bettina und Tournilhac, Olivier
(2021):
A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.
In: Blood, Bd. 137, Nr. 19: S. 2646-2656
2019
Friedrichs, Birte; Nickelsen, Maike; Ziepert, Marito; Altmann, Bettina; Haenel, Mathias; Viardot, Andreas; Schmidt, Christian; Ruebe, Christian; Löffler, Markus; Pfreundschuh, Michael; Rosenwald, Andreas; Glass, Bertram; Lenz, Georg und Schmitz, Norbert
(2019):
Doubling rituximab in high-risk patients with aggressive B-cell lymphoma -results of the DENSE-R-MegaCHOEP trial.
In: British Journal of Haematology, Bd. 184, Nr. 5: S. 760-768